Although HNF1A-AS1 is more highly expressed in the high-risk group compared to the low-risk group of EC patients, it shows decreased expression in the tumor group (comprising 159 EC samples) compared to the control group (11 normal samples). This evidence concerns the gene HNF1A and neoplasm.